Gelnique (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Gelnique drug offered from Actavis Pharma, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: Oxybutynin
SUBSTANCE NAME: OXYBUTYNIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA]
ROUTE: TRANSDERMAL
DOSAGE FORM: GEL
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-04-02
END MARKETING DATE: 0000-00-00


Gelnique HUMAN PRESCRIPTION DRUG Details:

Item DescriptionGelnique from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 28(mg/.92g)
START MARKETING DATE: 2012-04-02
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52544-041_eab01b57-bd14-4f36-9a81-f63d250fd132
PRODUCT NDC: 52544-041
APPLICATION NUMBER: NDA202513

Other OXYBUTYNIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Gelnique
Allergan, Inc.OXYTROL